Finally, Signature 3 is associated with inactivating mutations in BRCA1 and BRCA2 genes, indicating that abrogation of functional HR- and/or NHEJ-mediated repair contributes considerably to breast cancer development, even in patients not harbouring a germline mutation in either of these two genes. This evidence concerns the gene BRCA2 and breast cancer.